IFNGR1 and colorectal carcinoma: To confirm these observations, we used an IFNGR blocking antibody to inhibit IFNγ signaling in the CRC prior to SCFA stimulation and noted that this almost completely abrogated the upregulation of MHCI on the CRC cell surface (Figure 2D).